Kylo Peptides Review: Published Lot COAs, the Koi Rebrand, and What the Membership Actually Saves
Kylo Peptides publishes a certificate for every lot, indexed by the number printed on the vial. We look at what is verifiable, where the marketing runs ahead of the paperwork, and whether the lifetime membership is worth it.
Table of Contents
Kylo Peptides is the highest-scoring supplier in our vendor directory, and it is the one vendor whose central quality claim a researcher can check without asking permission. This review explains what the company actually publishes, what we verified independently, where the marketing runs ahead of the documentation, and who should and should not pay their prices.
Research-use disclaimer: Every compound discussed here is sold for laboratory research use only and is not intended for human consumption. Nothing in this review is medical advice, and vendor placement in our directory is not an endorsement of any use beyond controlled research.
The rebrand: Kylo was Koi
If you have sourced research peptides in the last few years you may know this operator as Koi Peptides, run by Koi Research Labs. The storefront rebranded to Kylo Peptides in 2026, and koipeptides.com is being wound down with customers migrated to the new site.
This matters for one practical reason. A brand-new vendor has no track record, and in a market where operators disappear and reappear under new names, a fresh domain is normally a reason for caution rather than confidence. That is not the situation here. Kylo carries forward the same facility, the same quality programme, and the same operating history, which is why we moved the existing record across rather than listing Kylo as a new entrant starting from zero. Researchers who bought from Koi are dealing with the same people.
We mention it plainly because a rebrand that nobody explains is exactly the pattern that should make a buyer nervous. This one has a straightforward explanation.
What they actually publish
The reason Kylo tops our rankings is not purity numbers. Every vendor claims high purity. The difference is that Kylo publishes the underlying certificates openly, in a public COA library, indexed by the lot number printed on the vial.
There is no email request, no account, and no gated portal. You can read the certificate for the specific lot you are about to buy before spending anything, and you can confirm the lot number on the arriving vial matches the certificate you read.
That closes the biggest verification gap in this industry. The common practice elsewhere is to publish one flattering certificate per product and reuse it across batches for months, so the document you read describes material that was synthesised long before the vial in your hand. A lot-matched certificate is a fundamentally different claim.
Each published certificate covers two things:
- HPLC purity, which tells you how much of the material is the target compound
- LC-MS identity confirmation, which tells you the material is actually the compound named on the label
Identity confirmation matters more than most buyers realise. A vial can be 99 percent pure and still be 99 percent of the wrong peptide. Mass spectrometry on every lot, rather than identity inferred from the synthesis route, is the part of Kylo's programme that is genuinely uncommon.
The purity data
Across the lots currently listed in their library, published HPLC purity runs from roughly 98.9 percent to 99.96 percent, with most compounds above 99 percent. Kylo states an average lot purity of 99.6 percent, and the individual published certificates are consistent with that figure.
| Compound | Published HPLC purity | Identity |
|---|---|---|
| GHK-Cu | 99.960% | LC-MS confirmed |
| SS-31 | 99.924% | LC-MS confirmed |
| KPV | 99.899% | LC-MS confirmed |
| Selank | 99.876% | LC-MS confirmed |
| NAD+ | 99.842% | LC-MS confirmed |
| Retatrutide | 99.760% | LC-MS confirmed |
| BPC-157 | 99.283% | LC-MS confirmed |
| TB-500 | 99.127% | LC-MS confirmed |
| Tesamorelin | 99.059% | LC-MS confirmed |
These are the vendor's own published figures, not our independent assay results. The point is not that we have verified each number in our own laboratory. The point is that each number is attached to a named issuing laboratory and a specific lot, which makes it falsifiable. A purity claim you can check is worth more than one you cannot, even before anyone checks it.
Who does the testing, precisely
This is the part of Kylo's story where the marketing runs ahead of the paperwork, and it is worth being exact about.
Kylo runs in-house analytical QC and then has released batches verified by an independent ISO/IEC 17025 accredited laboratory. Every certificate currently published in their COA library names the same independent lab, Freedom Diagnostics.
Their About page is headlined "Three Labs Test Every Vial Before It Ships," and the company states that additional independent laboratories are part of its release process. Certificates from those additional laboratories are not currently published, so we cannot verify that claim, and we have not scored it.
What we scored is what is publicly checkable: in-house QC plus independent accredited third-party verification at batch level. That is already the top band in our scoring methodology, so publishing the additional certificates would strengthen an already leading position rather than change the score. We would still like to see them, because a claim on an About page and a signed certificate are not the same class of evidence.
To be clear about a related point, third-party lab testing is not unique to Kylo. Several vendors in our directory carry batch-level third-party COAs. What distinguishes Kylo is that the certificates are published openly and matched to lot numbers, rather than described in prose or supplied on request.
Catalogue and pricing
The catalogue runs to more than one hundred compounds and blends, with synthesis and lyophilisation carried out in the United States. Coverage includes the heavily researched peptides such as BPC-157, TB-500, GHK-Cu, KPV, Selank, Semax, SS-31, Tesamorelin, CJC-1295 with Ipamorelin, and Retatrutide, alongside proprietary blends.
Now the honest part about cost. At list price Kylo is expensive. Individual vials run above budget suppliers, and if you are comparing a single vial on price alone, Kylo will lose that comparison to vendors whose certificates are in-house or absent entirely.
Kylo offers a one-time lifetime membership at 497 dollars that takes 50 percent off every product permanently, with no renewal. That changes the arithmetic substantially:
- For a researcher ordering regularly, member pricing lands below much of the market and the fee is recovered within a handful of orders
- For someone placing one small order, it does not make sense, and list price is what applies
Work out your own expected order volume before deciding. A lifetime membership is only good value if you actually intend to keep buying, and 497 dollars spent to save on two vials is not a saving.
What we would check before ordering
Kylo's transparency is an advantage precisely because it gives a buyer things to verify. Before placing an order:
- Look up the certificate for the specific lot of the product you want, not just the product page
- Confirm the lot number on the certificate matches the lot number printed on the vial when it arrives
- Check the certificate date against the current stock, since a COA library that has drifted out of date relative to what is shipping is a warning sign
- Confirm the issuing laboratory named on the certificate is a real accredited lab
Those four checks take a few minutes and they are possible here. At most vendors they are not.
Verdict
Kylo Peptides is our first recommendation where documentation integrity is the priority. The published, lot-matched, third-party COA library is the strongest verification practice in our directory, and it is the practice most directly connected to the question that actually matters: is the compound in the vial what the label says it is.
The reservations are straightforward and worth weighing. List pricing is high without the membership. The three-laboratory claim on their About page is not yet supported by published certificates, and until it is, it should be treated as a company statement rather than a verified fact. The rebrand from Koi is recent, so researchers should expect some rough edges while the migration completes.
None of those reservations touch the core reason for the ranking. You can check their work before you buy, and at almost every other vendor in this market, you cannot.
Disclosure: Know Your Peptide receives no compensation from Kylo Peptides or any other vendor listed in our directory. Rankings are produced by the scoring model published on our methodology page. Purity figures cited above are the vendor's published certificate values, independently checkable in their public COA library.
About the Author
KnowYourPeptide Research Team
KnowYourPeptide Research Team
Content produced by the KnowYourPeptide research and editorial team. All articles are written from peer-reviewed primary literature and reviewed for scientific accuracy by credentialed researchers before publication.
